This is Dermata's first issued U.S. patent for XYNGARI™, which uses its Spongilla technology to topically treat acne -- Dermata expects to announce topline results from its STAR-1 Phase 3 XYNGARI™ ...

Leading UK contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions, has completed the build of ...

According to Business Research Insights the Portable Home Ventilator Market expected to exhibit a CAGR of 10.5% by 2033.The ...

Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, ...

Thermo Fisher Scientific, the world leader in serving science, today announced the introduction of Olink® Reveal, setting a ...

Isomerase has formed a strategic partnership with BugBiome, which is focused on the discovery of novel targeted ...

SACRAMENTO, CALIFORNIA / ACCESS Newswire / January 28, 2025 / Paragon Health IT announced a strategic reorganization effective January 1, 2025. As part of this reorganization, Paragon Health IT will ...

A range of clinical topics will be covered throughout the year at the in-person events held in Southern California. NEWPORT BEACH, CALIFORNIA / ACCESS Newswire / January 28, 2025 / Glidewell has ...

AcceleDev Chemical LLC, a leading contract development and manufacturing organization (CDMO) specializing in custom synthesis and process development, is pleased to announce the appointment of Dr.

Legal & General Assurance Society Limited (“Legal & General”) has completed a £1.4 billion buy-in with the Sanofi Pension Scheme (“the Scheme”), securing the benefits of 4,900 retirees and 5,600 ...

AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone receptor (HR)-positive, ...

OncoZenge AB (publ) (“OncoZenge” or the “Company”) announces that the Company has entered into an investment agreement (the “Investment Agreement”)whereby the Chinese investor Sichuan Yangtian ...